Document is current
Any future updates will be listed below
-
Authors
Ayata, Pinar https://orcid.org/0000-0001-7621-832X
Crowley, Jessica M.
Challman, Matthew F.
Sahasrabuddhe, Vinaya https://orcid.org/0000-0003-0857-0326
Gratuze, Maud
Werneburg, Sebastian
Ribeiro, Diogo https://orcid.org/0000-0001-6199-3120
Hays, Emma C.
Durán-Laforet, Violeta
Faust, Travis E. https://orcid.org/0000-0002-4567-8435
Hwang, Philip
Mendes Lopes, Francisco
Nikopoulou, Chrysa
Buchholz, Sarah
Murphy, Robert E.
Mei, Taoyu https://orcid.org/0000-0003-0865-9259
Pimenova, Anna A.
Romero-Molina, Carmen
Garretti, Francesca
Patel, Tulsi A.
De Sanctis, Claudia
Ramirez Jimenez, Angie V.
Crow, Megan
Weiss, Felix D. https://orcid.org/0000-0003-0228-5081
Ulrich, Jason D. https://orcid.org/0000-0002-4743-926X
Marcora, Edoardo https://orcid.org/0000-0002-3829-4927
Murray, John W. https://orcid.org/0000-0002-4347-7824
Meissner, Felix https://orcid.org/0000-0003-1000-7989
Beyer, Andreas https://orcid.org/0000-0002-3891-2123
Hasson, Dan
Crary, John F. https://orcid.org/0000-0002-0556-293X
Schafer, Dorothy P.
Holtzman, David M. https://orcid.org/0000-0002-3400-0856
Goate, Alison M. https://orcid.org/0000-0002-0576-2472
Tarakhovsky, Alexander
Schaefer, Anne https://orcid.org/0000-0002-1051-3710
- License Information
-
More Information
Article History
Received: 12 August 2024
Accepted: 22 September 2025
First Online: 5 November 2025
Competing interests
: A.M.G. receives financial compensation as an advisory board member for Genentech and Muna Therapeutics. D.M.H. is an inventor on a patent licenced by Washington University to NextCure on the therapeutic use of anti-apoE antibodies. D.M.H. co-founded, has equity and is on the scientific advisory board of C2N Diagnostics. D.M.H. is on the scientific advisory boards of Denali, Genentech and Acta and consults for Pfizer, Roche and Switch Therapeutics. M.C. is an employee of Genentech. The remaining authors declare no competing interests.
